Key result
Aspirin, intravenous immunoglobulins, corticosteroids, and biological agents are utilized to manage Kawasaki disease and prevent the development of coronary artery aneurysms.
Why the study?
Kawasaki disease carries a risk of coronary artery lesions with significant morbidity and mortality, but predicting the risk of coronary artery aneurysm remains challenging.
Design
Narrative review
Authors
Loading...
Risk prediction for coronary aneurysms in Kawasaki disease remains imprecise; leaves open need for validated models in prospective studies.
This narrative review summarizes the pathogenesis, genetic factors, and therapeutic strategies for preventing coronary artery aneurysms in children with Kawasaki disease.
Rajasekaran et al. (2022) conducted a review in Kawasaki disease. Aspirin, intravenous immunoglobulins, corticosteroids, and biological agents are utilized to manage Kawasaki disease and prevent the development of coronary artery aneurysms.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: